null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

The Cancer Atlas

List Price: $29.95
SKU:
9781604432282
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Ahmedin Jemal
    Format:
    Paperback
    Pages:
    136
    Publisher:
    American Cancer Society (April 1, 2015)
    Language:
    English
    ISBN-13:
    9781604432282
    ISBN-10:
    1604432284
    Weight:
    23.2oz
    Dimensions:
    9" x 11" x 0.5"
    Case Pack:
    24
    File:
    Eloquence-IPG_07022025_P8798719_onix30_Complete-20250702.xml
    Folder:
    Eloquence
    As low as:
    $25.76
    List Price:
    $29.95
    Publisher Identifier:
    P-IPG
    Discount Code:
    C
    Audience:
    General/trade
    Pub Discount:
    60
    Imprint:
    American Cancer Society
  • Overview

    This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.